Benefits of NGS for Precision Oncology

 

Next-generation sequencing (NGS) offers deep understandings in precision oncology to empower more personalized treatment options. Learn how NGS is being used in oncology to enable biomarker profiling to understand what drives cancer and its mutations. See how NGS can streamline cancer profiling and improve patient outcomes.

 

Next-generation Sequencing in Oncology

Before the existence of next-generation sequencing technologies, cancer treatment therapies were implemented based on cancer type alone. NGS has become a driver for precision oncology and enables clinicians to personalize treatment based on specific cancer biomarkers. Learn More

 

patient-outcomes

challenging-paradigm

One-Day NGS for
Cancer Centers

By bringing NGS testing in-house, oncologists can gain deeper insights into cancer genomic drivers at a quicker rate. This enables more targeted treatment options for patients faster than other methods. Learn More

Improved Patient Outcomes

NGS is proven to improve outcomes for patients by accelerating targeted treatment. Read our stories on how NGS technology is advancing cancer care in hospitals and cancer centers.
Read Stories

Elderly patient looking at a nurse in hospital ward

NGS-comprehensive-genomic-profiling-oncomine

 

Hospital Economics of NGS

Outsourcing NGS cancer testing can be stressful for both clinicians and patients as long wait times to receive results can mean live or death. There are many benefits for hospitals to bring NGS technology in-house including faster test turnaround times, better care, reduced labor costs and more. Learn More

Is comprehensive genomic profiling (CGP)
the answer to everything ?

No, one size does not fit all. For example, let’s take non-small cell lung cancer (NSCLC) samples. All biomarkers relevant for clinical research can be tested by one, 50 gene targeted panel. It’s cheaper, faster, and it requires less sample input, which is critical in NSCLC, where “tissue is still an issue”. There are four key scenarios in which comprehensive genomic profiling
would be most impactful.

Learn about them in The Pathologist Article “A Comprehensive Answer for Cancer”.

Have questions?  We look forward to speaking with you about bringing NGS to your lab.

speak-with-ngs-expert-cta

 

Subscribe to receive the latest news about NGS in
precision oncology.

subscribe-now-cta

 

Are you a healthcare professional?

あなたは医療関係者ですか?



We've detected your location to be Japan.

Sorry, this page is not available in your area.